Published in Curr Top Microbiol Immunol on January 01, 1990
Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell (2010) 4.47
Biochemical and genetic evidence for a pseudoknot structure at the 3' terminus of the poliovirus RNA genome and its role in viral RNA amplification. J Virol (1993) 2.65
Viral movement proteins as probes for intracellular and intercellular trafficking in plants Plant Cell (1999) 2.40
Oligomeric structures of poliovirus polymerase are important for function. EMBO J (2001) 2.27
Visualization of double-stranded RNA in cells supporting hepatitis C virus RNA replication. J Virol (2007) 2.15
RNA-protein interactions: involvement of NS3, NS5, and 3' noncoding regions of Japanese encephalitis virus genomic RNA. J Virol (1997) 2.12
Towards identification of cis-acting elements involved in the replication of enterovirus and rhinovirus RNAs: a proposal for the existence of tRNA-like terminal structures. Nucleic Acids Res (1992) 2.04
Capsid coding sequence is required for efficient replication of human rhinovirus 14 RNA. J Virol (1996) 1.85
Replication-competent picornaviruses with complete genomic RNA 3' noncoding region deletions. J Virol (1997) 1.73
A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA. J Virol (1995) 1.70
Identification of terminal adenylyl transferase activity of the poliovirus polymerase 3Dpol. J Virol (1994) 1.52
RNA duplex unwinding activity of poliovirus RNA-dependent RNA polymerase 3Dpol. J Virol (1993) 1.51
Replication of the genomic RNA of a positive-strand RNA animal virus from negative-sense transcripts. Proc Natl Acad Sci U S A (1994) 1.49
Inefficient complementation activity of poliovirus 2C and 3D proteins for rescue of lethal mutations. J Virol (1995) 1.40
Poliovirus protein 3AB forms a complex with and stimulates the activity of the viral RNA polymerase, 3Dpol. J Virol (1995) 1.37
trans rescue of a mutant poliovirus RNA polymerase function. J Virol (1991) 1.35
Poliovirus infection enhances the formation of two ribonucleoprotein complexes at the 3' end of viral negative-strand RNA. J Virol (1995) 1.34
RNA-protein interactions directed by the 3' end of human rhinovirus genomic RNA. J Virol (1995) 1.32
Structure-infectivity analysis of the human rhinovirus genomic RNA 3' non-coding region. Nucleic Acids Res (1996) 1.13
VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus. J Virol (1992) 1.10
Mutation of lysine residues in the nucleotide binding segments of the poliovirus RNA-dependent RNA polymerase. J Virol (1996) 1.09
Transduction of a human RNA sequence by poliovirus. J Virol (1994) 1.06
Requirements for RNA replication of a poliovirus replicon by coxsackievirus B3 RNA polymerase. J Virol (1999) 1.05
An authentic 3' noncoding region is necessary for efficient poliovirus replication. J Virol (2005) 0.99
Temperature-sensitive mouse cell factors for strand-specific initiation of poliovirus RNA synthesis. J Virol (1993) 0.96
Reverse transcriptase activity in mature spermatozoa of mouse. J Cell Biol (2000) 0.87
Evolution of poliovirus defective interfering particles expressing Gaussia luciferase. J Virol (2011) 0.80
Improved genotyping vaccine and wild-type poliovirus strains by restriction fragment length polymorphism analysis: clinical diagnostic implications. J Clin Microbiol (2000) 0.78
Emergence of distinct brome mosaic virus recombinants is determined by the polarity of the inoculum RNA. J Virol (2012) 0.77
Conformational Ensemble of the Poliovirus 3CD Precursor Observed by MD Simulations and Confirmed by SAXS: A Strategy to Expand the Viral Proteome? Viruses (2015) 0.75
Translation of poliovirus RNA in vitro: changes in cleavage pattern and initiation sites by ribosomal salt wash. Virology (1979) 3.61
Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology (1994) 3.52
Poly (rC) binding protein 2 forms a ternary complex with the 5'-terminal sequences of poliovirus RNA and the viral 3CD proteinase. RNA (1997) 3.47
Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA. J Virol (1997) 3.40
Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol (1988) 3.28
Double-stranded poliovirus RNA inhibits initiation of protein synthesis by reticulocyte lysates. Proc Natl Acad Sci U S A (1971) 2.99
Poly(rC) binding protein 2 binds to stem-loop IV of the poliovirus RNA 5' noncoding region: identification by automated liquid chromatography-tandem mass spectrometry. Proc Natl Acad Sci U S A (1996) 2.82
Isolation of a viral polypeptide associated with poliovirus RNA polymerase. Proc Natl Acad Sci U S A (1974) 2.79
Translation of poliovirus RNA in vitro: detection of two different initiation sites. J Mol Biol (1975) 2.58
Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing. J Virol (1988) 2.32
Control of protein synthesis in extracts from poliovirus-infected cells. I. mRNA discrimination by crude initiation factors. J Virol (1978) 2.31
An internal 5'-noncoding region required for translation of poliovirus RNA in vitro. J Virol (1988) 2.29
Soluble RNA polymerase complex from poliovirus-infected HeLa cells. Virology (1970) 2.26
Formation of the poliovirus replication complex requires coupled viral translation, vesicle production, and viral RNA synthesis. J Virol (2000) 2.13
Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells. J Virol (1997) 2.13
Adenylate-rich sequences in vesicular stomatitis virus messenger ribonucleic acid. J Virol (1972) 2.05
Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A. Virology (1986) 2.02
Differential utilization of poly(rC) binding protein 2 in translation directed by picornavirus IRES elements. RNA (1999) 2.00
Untranslated vesicular stomatitis virus messenger RNA after poliovirus infection. Virology (1977) 1.92
Sub-cellular localization of vesicular stomatitis virus messenger RNAs. Biochem Biophys Res Commun (1975) 1.91
In vitro synthesis of proteins by membrane-bound polyribosomes from vesicular stomatitis virus-infected HeLa cells. J Virol (1974) 1.90
Demonstration in vitro that eucaryotic initiation factor 3 is active but that a cap-binding protein complex is inactive in poliovirus-infected HeLa cells. J Virol (1984) 1.87
Th size and shape of bacteria by light scattering measurements. Biochim Biophys Acta (1968) 1.85
Poliovirus-induced inhibition of host-cell protein synthesis. Cell (1982) 1.79
Alterations in initiation factor activity from poliovirus-infected HeLa cells. J Biol Chem (1979) 1.75
The cap-binding protein complex in uninfected and poliovirus-infected HeLa cells. J Biol Chem (1987) 1.73
Cytoplasm from poliovirus-infected HeLa cells inhibits cell-free haemoglobin synthesis. Nat New Biol (1971) 1.72
Genetic and physiological analysis of conjugation in Streptococcus faecalis. J Bacteriol (1982) 1.72
Synthesis of plus- and minus-strand RNA from poliovirion RNA template in vitro. J Virol (1986) 1.60
Eukaryotic initiation factor 3 is required for poliovirus 2A protease-induced cleavage of the p220 component of eukaryotic initiation factor 4F. Proc Natl Acad Sci U S A (1990) 1.58
Comparison of replication complexes synthesizing poliovirus RNA. Virology (1981) 1.55
The 5'-terminal nucleotides of hepatitis A virus RNA, but not poliovirus RNA, are required for infectivity. J Virol (1991) 1.55
Identification of terminal adenylyl transferase activity of the poliovirus polymerase 3Dpol. J Virol (1994) 1.52
RNA duplex unwinding activity of poliovirus RNA-dependent RNA polymerase 3Dpol. J Virol (1993) 1.51
Requirements for assembly of poliovirus replication complexes and negative-strand RNA synthesis. J Virol (2001) 1.50
Purification, characterization, and comparison of poliovirus RNA polymerase from native and recombinant sources. J Biol Chem (1991) 1.49
Effects of mutations in poliovirus 3Dpol on RNA polymerase activity and on polyprotein cleavage. J Virol (1989) 1.48
Poliovirus protease does not mediate cleavage of the 220,000-Da component of the cap binding protein complex. Proc Natl Acad Sci U S A (1985) 1.47
Restriction of translation of capped mRNA in vitro as a model for poliovirus-induced inhibition of host cell protein synthesis: relationship to p220 cleavage. J Virol (1987) 1.41
Inefficient complementation activity of poliovirus 2C and 3D proteins for rescue of lethal mutations. J Virol (1995) 1.40
Effect of poliovirus double-stranded RNA on viral and host-cell protein synthesis. Proc Natl Acad Sci U S A (1974) 1.39
Polyadenylation of vesicular stomatitis virus mRNA. J Virol (1974) 1.39
Association of cap-binding protein with eucaryotic initiation factor 3 in initiation factor preparations from uninfected and poliovirus-infected HeLa cells. J Virol (1982) 1.38
Capsid protein precursor is one of two initiated products of translation of poliovirus RNA in vitro. J Virol (1979) 1.37
Characterization of a cell culture persistently infected with the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1982) 1.37
trans rescue of a mutant poliovirus RNA polymerase function. J Virol (1991) 1.35
Presence of the cap-binding protein in initiation factor preparations from poliovirus-infected HeLa cells. J Virol (1981) 1.35
Specific interactions of HeLa cell proteins with proposed translation domains of the poliovirus 5' noncoding region. J Virol (1992) 1.34
Expression of the fibronectin-binding components of Streptococcus pyogenes in Escherichia coli demonstrates that they are proteins. Mol Microbiol (1991) 1.31
Viral polypeptides associated with the RNA replication complex in poliovirus-infected cells. Virology (1980) 1.31
Host factor-induced template modification during synthesis of poliovirus RNA in vitro. J Virol (1987) 1.29
Enzymatic activity of poliovirus RNA polymerase synthesized in Escherichia coli from viral cDNA. Virology (1988) 1.26
Inhibition of host cell protein synthesis by UV-inactivated poliovirus. J Virol (1977) 1.26
Full-length viral RNA synthesized in vitro by vesicular stomatitis virus-infected HeLa cell extracts. Virology (1979) 1.26
Host cell proteins binding to domain IV of the 5' noncoding region of poliovirus RNA. J Virol (1995) 1.26
Relationship of eukaryotic initiation factor 3 to poliovirus-induced p220 cleavage activity. J Virol (1992) 1.25
Studies on the in vivo and in vitro messenger RNA species of vesicular stomatitis virus. Virology (1975) 1.23
Analysis of a potential myristoylation site in hepatitis A virus capsid protein VP4. Virology (1993) 1.22
Interaction of poly(rC) binding protein 2 with the 5' noncoding region of hepatitis A virus RNA and its effects on translation. J Virol (1998) 1.22
Formation of poliovirus RNA polymerase 3D in Escherichia coli by cleavage of fusion proteins expressed from cloned viral cDNA. Virology (1987) 1.20
Structure of poliovirus replicative intermediate RNA. Electron microscope analysis of RNA cross-linked in vivo with psoralen derivative. J Mol Biol (1984) 1.19
Induction of intracellular membrane rearrangements by HAV proteins 2C and 2BC. Virology (1997) 1.19
Hepatitis A virus polyprotein synthesis initiates from two alternative AUG codons. Virology (1992) 1.19
Rapid completion of the replication cycle of hepatitis A virus subsequent to reversal of guanidine inhibition. Virology (1991) 1.17
Hepatitis A virus capsid protein VP1 has a heterogeneous C terminus. J Virol (1999) 1.15
Proteolytic activity of hepatitis A virus 3C protein. J Virol (1991) 1.15
Polyprotein processing in cis and in trans by hepatitis A virus 3C protease cloned and expressed in Escherichia coli. J Virol (1992) 1.14
Initiation factor preparations from poliovirus-infected cells restrict translation in reticulocyte lysates. Virology (1980) 1.13
The effect of poliovirus infection on the translation in vitro of VSV messenger ribonucleoprotein particles. Virology (1983) 1.12
Primary cleavage of the HAV capsid protein precursor in the middle of the proposed 2A coding region. Virology (1993) 1.09
Mutation of lysine residues in the nucleotide binding segments of the poliovirus RNA-dependent RNA polymerase. J Virol (1996) 1.09
Restricted replication of vesicular stomatitis virus in human lymphoblastoid cells. J Virol (1973) 1.08
Cytoplasmic and nuclear pyrimidine ribonucleotide pools in HeLa cells. J Mol Biol (1973) 1.07
Effects of poliovirus 3AB protein on 3D polymerase-catalyzed reaction. J Biol Chem (1998) 1.06
Requirements for RNA replication of a poliovirus replicon by coxsackievirus B3 RNA polymerase. J Virol (1999) 1.05
Translation of hepatitis A virus RNA in vitro: aberrant internal initiations influenced by 5' noncoding region. Virology (1991) 1.04
Detection of hepatitis A virus RNA and capsid antigen in individual cells. Virus Res (1989) 1.04
Heterogeneity of the 3' end of minus-strand RNA in the poliovirus replicative form. J Virol (1980) 1.04
Detection of hepatitis A virus proteins in infected BS-C-1 cells. Virology (1991) 1.00
Replication of hepatitis A viruses with chimeric 5' nontranslated regions. J Virol (1996) 0.99
trans-encapsidation of a poliovirus replicon by different picornavirus capsid proteins. J Virol (1998) 0.99
Strand-specific attachment of avidin-spheres to double-stranded poliovirus RNA. Proc Natl Acad Sci U S A (1979) 0.98
Temperature-sensitive polioviruses containing mutations in RNA polymerase. Virology (1992) 0.98
Coding sequences enhance internal initiation of translation by hepatitis A virus RNA in vitro. J Virol (1998) 0.98
Expression of hepatitis A virus precursor protein P3 in vivo and in vitro: polyprotein processing of the 3CD cleavage site. Virology (1994) 0.98
Nucleotide binding by the poliovirus RNA polymerase. J Biol Chem (1992) 0.97
Localization of cap-binding protein in subcellular fractions of HeLa cells. Mol Cell Biol (1982) 0.96
One of two NTP binding sites in poliovirus RNA polymerase required for RNA replication. J Biol Chem (1997) 0.96
Translation of poliovirus RNA in vitro: studies on n-formylmethionine-labeled polypeptides initiated in cell-free extracts prepared from poliovirus infected HeLa cells. Virology (1979) 0.96
Two initiation sites for translation of poliovirus RNA in vitro: comparison of LSc and Mahoney strains. J Virol (1978) 0.96
Two-dimensional gel analyses of the 24-kDa cap binding protein from poliovirus-infected and uninfected HeLa cells. Virology (1986) 0.95
Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli. J Infect Dis (1988) 0.95
Identification of nucleotide binding sites in the poliovirus RNA polymerase. Biochemistry (1995) 0.94
Characterization of persistent poliovirus mutants selected in human neuroblastoma cells. Virology (1991) 0.93
HeLa cell nucleolar RNA synthesis after poliovirus infection. Virology (1973) 0.93
Effect of D-penicillamine on poliovirus replication in HeLa cells. J Virol (1974) 0.93
Hepatitis A viruses with deletions in the 2A gene are infectious in cultured cells and marmosets. J Virol (1995) 0.91
Analysis of Theiler's virus isolates from persistently infected mouse nervous tissue. J Gen Virol (1983) 0.90
Stability of poliovirus RNA in cell-free translation systems utilizing two initiation sites. J Biol Chem (1981) 0.90